Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia
Annotation
Nick Goulden,
Anthony Oakhill,
Colin Steward,
Nick Goulden
University of Bristol and Bristol Children's Hospital, Bristol, UK. E-mail: [email protected]
Search for more papers by this authorAnthony Oakhill
University of Bristol and Bristol Children's Hospital, Bristol, UK. E-mail: [email protected]
Search for more papers by this authorColin Steward
University of Bristol and Bristol Children's Hospital, Bristol, UK. E-mail: [email protected]
Search for more papers by this authorNick Goulden,
Anthony Oakhill,
Colin Steward,
Nick Goulden
University of Bristol and Bristol Children's Hospital, Bristol, UK. E-mail: [email protected]
Search for more papers by this authorAnthony Oakhill
University of Bristol and Bristol Children's Hospital, Bristol, UK. E-mail: [email protected]
Search for more papers by this authorColin Steward
University of Bristol and Bristol Children's Hospital, Bristol, UK. E-mail: [email protected]
Search for more papers by this author Dr Nick Goulden, Senior Lecturer in Paediatric Haematology, University of Bristol and Bristol Children's Hospital, Oncology Day Beds, Bristol Children's Hospital, St Michael's Hill, Bristol BS2 8JD, UK. E-mail: [email protected]
References
- Aversa, F., Tabilio, A., Velardi, F., Falzetti, S., Ballanti, A., Carotti. F., Falcinelli, F., Santucci, K., Perruccio, K., Resiner, Y. & Martelli, M.F. (1999) Advances in full haplotype mismatched transplants in acute leukemia (Abstract). Blood, 94, 565a.
- Brisco, M.J., Condon, J., Hughes, E., Neoh, S.-H., Nicholson, I., Sykes, P.J., Tauro, G., Ekert, H., Waters, K., Toogood, I., Seshadri, R. & Morley, A.A. (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantitation of minimal residual disease at the end of induction. Lancet, 343, 196–200.
- Brisco, M.J., Sykes, P.J., Hughes, E., Dolman, G., Neoh, S.H., Peng, L.M., Toogood, I. & Morley, A.A. (1997) Monitoring minimal residual disease in peripheral blood in B-lineage ALL. British Journal of Haematology, 99, 314–319.
- Campana, D. & Coustan-Smith, E. (1999) Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry, 15, 139–152.
- Cave, H., Van Der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandachamp, B. & Vilmer, E. (1998) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organisation for Research and Treatment of Cancer-Childhood Leukemia Co-operative Group. New England Journal of Medicine, 339, 591–598.
- Chessells, J.M. (1998) Relapsed lymphoblastic leukaemia in children: a continuing challenge. British Journal of Haematology, 102, 423–438.DOI: 10.1046/j.1365-2141.1998.00776.x
- Chessells, J.M., Bailey, C.C. & Richards, S.M. (1992) MRC UKALLX. The U.K. protocol for childhood ALL 1985–90. Leukemia, 6, 157–161.
- Coustan-Smith, E., Behm, F.G., Sanchez, J., Boyett, J.M., Hancock, M.L., Raimondi, S.C., Rubnitz, J.E., Rivera, G.K., Sandlund, J.T., Pui, C.H. & Campana, D. (1998) Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet, 351, 550–554.DOI: 10.1016/s0140-6736(97)10295-1
- Cross, N.C.P., Feng, L. & Chase, A. (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82, 1929–1936.
- Eden, O.B., Lilleyman, J.S., Richards, S., Shaw, M.P. & Peto, J. (1991) Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). British Journal of Haematology, 78, 187–196.
- Evans, P.A., Short, M.A., Owen, R.G., Jack, A.S., Forsyth, P.D., Shiach, C.R., Kinsey, S. & Morgan, G.J. (1998) Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 16, 3616–3627.
- Foroni, L., Harrison, C.J., Hoffbrand, A.V. & Potter, M.N. (1999) Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. British Journal of Haematology, 105, 7–24.
- Goulden, N.J., Knechtli, C.J.C., Garland, R., Langlands, K., Hancock, J.P., Potter, M.N., Steward, C.G. & Oakhill, A., (1998) Minimal residual disease analysis for the prediction of relapse in children with standard risk acute lymphoblastic leukaemia. British Journal of Haematology, 100, 235–244.DOI: 10.1046/j.1365-2141.1998.00574.x
- Heslop, H.E. (1999) Haemopoietic stem cell transplantation from unrelated donors. British Journal of Haematology, 105, 2–6.
- Knechtli, C.J.C., Goulden, N.J., Hancock, J.P., Garland, R.J., Jones, C.G., Grandage, V., Rowbottom, A.W., Green, A.F., Clarke, E., Lankester, A.W., Potter, M.N., Cornish, J.M.M., Pamphilon, D.H., Steward, C.G. & Oakhill, A. (1998a) Minimal residual status as a predictor of relapse after allogeneic bone marrow transplant for children with acute lymphoblastic leukaemia. British Journal of Haematology, 102, 860–876.DOI: 10.1046/j.1365-2141.1998.00873.x
- Knechtli, C.J.C., Goulden, N.J., Hancock, J.P., Garland, R.J., Jones, C.G., Grandage, V., Rowbottom, A.W., Green, A.F., Clarke, E., Lankester, A.W., Potter, M.N., Cornish, J.M.M., Pamphilon, D.H., Steward, C.G. & Oakhill, A. (1998b) Minimal residual disease status prior to allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood, 92, 4072–4079.
- Martens, A.C.M., Schultz, F.W. & Hagenbeek, A. (1987) Non-homogeneous distribution of leukemia in the bone marrow during minimal residual disease. Blood, 70, 1073–1078.
- Nachman, J.B., Sather, H.N., Sensel, M.G., Trigg, M.E., Cherlow, J.M., Lukens, J.N., Wolff, L., Uckun, F.M. & Gaynon, P.S. (1998) Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. New England Journal of Medicine, 338, 1663–1671.
- Neale, G.A., Coustan-Smith, E., Pan, Q., Chen, X., Gruhn, B., Stow, P., Behm, F.G., Pui, C.H. & Campana, D. (1999) Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia, 13, 1221–1226.
- Ouspenskaia, V., Johnston, D.A., Roberts, W.M., Estrov, Z. & Zipf, T. (1995) Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR based detection system; a description of the method and the principles involved. Leukemia, 9, 321–328.
- Owen, R.G., Goulden, N.J., Oakhill, A., Shiach, C., Evans, P.A., Potter, M.N. & Morgan, G.J. (1997) Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL. British Journal of Haematology, 97, 457–459.
- Pui, C.H., Evans, W.E. & Gilbert, J.R. (1998) Meeting Report: International Childhood ALL Workshop Memphis TN 3–4 December 1997. Leukemia, 12, 1313–1318.
- Pongers-Willemse, M.J., Verhagen, O.J., Tibbe, G.J., Wijkhuijs, A.J., De Haas, V., Roovers, E., Van Der Schoot, C.E. & Van Dongen, J.J. (1998) Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia, 12, 2006–2014.
- Pongers-Willemse, M.J., Seriu, T., Stolz, F., D'aniello, E., Gameiro, P., Pisa, P., Gonzalez, M., Bartram, C.R., Panzer-Grumayer, E.R., Biondi, A., San Miguel, J.F. & Van Dongen, J.J. (1999) Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia, 13, 1901–1928.
- Rivera, G. (1994) Therapy for childhood non-B-lymphoblastic leukaemia. Bailliere's Clinical Haematology, 7, 273–298.
- Roberts, W.M., Estrov, Z., Kitchingham, G. & Zipf, T. (1996) The clinical significance of residual disease analysis in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification of antigen receptor gene sequences. Leukaemia and Lymphoma, 20, 181–197.
- San Miguel, J.F., Ciudad, J., Vidriales, M.B., Orfao, A., Lucio, P., Porwit-MacDonald, A., Gaipa, G., Van Wering, E. & Van Dongen, J.J. (1999) Immunophenotypical detection of minimal residual disease in acute leukemia. Reviews in Oncology and Hematology, 32, 175–85.
- Sczepanski, T., Willemse, M.J., Van Wering, E. & Van Dongen, J.J. (1999) Clonal incomplete DH-JH rearrangements occur in 20% of children with precursor B-ALL: implications for minimal residual disease monitoring. Blood, 94, 289a(Abstract).
- Sykes, P.J., Brisco, M.J., Hughes, E., Snell, L.E., Dolman, G., Neoh, S.H., Peng, L.M., Toogood, I., Venables, W.N. & Morley, A.A. (1998) Minimal residual disease in childhood acute lymphoblastic leukaemia quantified by aspirate and trephine: is the disease multifocal? British Journal of Haematology, 105, 60–65.
- Van Dongen, J.J., Seriu, T., Panzer-Grumayer, E.R., Biondi, A., Pongers-Willemse, M.J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W.A., Gadner, H., Van Wering, E.R., Ludwig, W.D., Basso, G., De Bruijn, M.A., Cazzaniga, G., Hettinger, K., Van Der does-van den Berg, A., Hop, W.C., Riehm, H. & Bartram, C.R. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet, 352, 1731–1738.DOI: 10.1016/s0140-6736(98)04058-6
- Zur Stadt, U., Harms, D.O., Schluter, S., Scxhrappe, M., Gobel, H., Spaar, H., Janka, G. & Kabisch, H. (1999) Outcome prediction by means of MRD at the end of induction therapy in childhood acute lymphoblastic leukemia strongly depends on the therapeutic regimen: a report of the German COALL study. (Abstract) Blood, 94, 284a
Citing Literature
